Biocore9 Llc – FDA 483, Nov 6, 2023
An FDA inspection of Biocore9 LLc, a specification developer in Whippany, NJ, revealed significant deficiencies in its quality system related to the manufacture of sterile humeral and femoral head resurfacing systems. The firm failed to adequately validate sterilization processes, perform complete risk analyses, qualify suppliers, and establish proper design controls. Additionally, issues were noted with non-conforming product procedures, management review, internal audits, and medical device reporting.
ID · 249b2928-693e-4f4c-9411-f4e1b0ba1c38
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.